A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19
vaccine, coronavirus, Pandemic, SARS-CoV-2, COVID-19
Coronavirus disease 19 (COVID-19) is a challenge to the whole humanity. COVID-19 was first reportedin China and rigorous researches are going on for developing vaccine for the pandemic. This review wasprepared by following PRISMA guidelines and used the resources from the Web of Science and PubMed.This research focuses on the niches of symptoms and vaccines for COVID-19. The research for vaccineinvolves research for new vaccine and drug repurposing. Out of various drug repurposing options,Remdesivir, and Favipiravir, Chloroquine and Lopinavir/Ritonavir were found to be the popular onesfor treating COVID-19 patients across the world. Even though there are concerns regarding asymptoticpatients, the most dominant symptoms of COVID-19 are fever and cough, followed by Dyspnoea andmuscle ache. This review concludes that the COVID-19 related research should focus on developingimmunity vaccines, and repurposing of drugs. Research on the problems of quarantine life, patientmonitoring, and usage of information technology in facing COVID-19 will improve the quality of patienthandling during the pandemic. The research on the effectiveness of various models of lockdown andregulation of social life during lockdown periods, improving the safety of health care workers in theworkplace will definitely help the governments in their fight against COVID-19.
Journal of Pure and Applied Microbiology